Real-World Evidence for the Safety of Ipragliflozin in Elderly Japanese Patients With Type 2 Diabetes Mellitus (STELLA-ELDER): Final Results of a Post-Marketing Surveillance Study

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1080/14656566.2016.1219341
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search